Editorial Team

Editor in Chief

    John W. Oller, Jr., PhD in General Linguistics from the University of Rochester in New York, now a professor at IPAKnowledge.org and consultant to Veritas International University, formerly a tenured faculty member consecutively at the University of California at Los Angeles, the University of New Mexico, and the University of Louisiana; a theoretician and experimentalist with expertise in information theory and in the development of language and biosignaling systems across time, especially, how they are impacted by toxicants, traumatic injuries (macro or micro), pathogens, emotional stress, and the interactions of injurious factors leading to breakdowns, disorders, diseases, and death, mailto: [email protected]

Senior Editor   Christopher A. Shaw, PhD, Professor, Department of Ophthalmology, University of British Columbia, 828 W. 10th Ave, Vancouver, BC, V5Z 1L8 expertise in the dynamics of neurological disease and in experimental modeling of the impact of toxicants such as aluminum adjuvants on mouse and human biochemistry; mailto: [email protected]

Associate Editors

  Russell Blaylock, MD, nationally recognized board-certified neurosurgeon, health practitioner, author, and lecturer; practiced 26 years in neurosurgery; serves as  Associated Editor-in-Chief of the Neuroinflammation Section of Surgical Neurology International

   Robert M. Davidson, MD, PhD, Certified by the American Board of Nuclear Medicine 1990; also by the American Board of Internal Medicine 1996; Fellow of the American Institute of Stress; expertise in the broad spectrum of human biochemistry, toxicants, pharmaceuticals, vaccines, and medicine

   Gayle DeLong, Associate Professor, Bert W. Wasserman Department of Economics and Finance, City University of New York (CUNY), Baruch College, New York, NY 10021, USA; Author of professional works on vaccine (product) safety relative to "delitigation" and "conflicts of interest"

   Richard C. Deth, PhD, Professor of Pharmacology, Department of Pharmaceutical Sciences, College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA; expertise in pharmaceutical aspects of vaccine components and toxicology

   Mary S. Holland, MA, JD, General Counsel for Children's Health Defense 2019-present; formerly Director Graduate Lawyering Program, New York University School of Law 2004-2019; expertise in children's health and litigation concerning vaccines; renowned author of works in that area

   J. J. Kartzinel, MD, Fellow of the American Academy of Pediatrics, Kartzinel Wellness Center; expertise as clinician practitioner treating autism and related neurological disorders

   Robert J. Krakow, JD, Law Office of Robert J. Krakow, Representing the Vaccine Injured in All 50 States

   David L. Lewis, PhD, Professor and Member of the Graduate Faculty, University of Georgia, Research Director at Focus for Health Science for Sale, Skyhorse Publishing Watchung, NJ, Winner of the Sierra Club Distinguished Service Award 2018; and Winner of the US EPA Science Achievement Award 2000; expertise in environmental health risks associated with vaccines 

   James Lyons-Weiler, PhD, CEO, President and Director of the Institute for Pure and Applied Knowledge at the University of Pittsburgh, Pennsylvania; PhD in Ecology, Evolution & Conservation in Biology; postdoctoral fellow in Computational Molecular Biology at Pennsylvania State University; Senior Research Scientist, and Scientific Director in support of translational research, systems biology, sequence analysis, and algorithmic solutions for big data in bioinformatics; Editor-in-Chief of the journal Science, Public Health Policy, and the Law; research interests and published works cover autism/ASD, biomarker development for complex disorders, immunology, toxicology, cancer biology, cancer receptors, phased biomarker development, microarray data analysis, proteomic data analysis, machine-learning based prediction model optimization, and information theory

   Dana Butnaru Medis, MD, PhD in progress, founder of DANAMEDIS Institute of Immunological Research; expert in autoimmunity, neuroimmunology, immune-mediated female infertility, immunodeficiency and immuno-nutrition; her most recent ground-breaking work pertains to prion/prion-like disease involving protein misfolding particularly impacting the immunocompetence of the CNS by corrupting the microglia in a battleground of great importance to the post-COVID-19 world

   Stefano Montanari, Doctorate in Pharmacy with a dissertation in michrochemistry;  Director of the Nanodiagnostics Laboratory of Modena since 2004, inventor of caval filtration devices, a prosthetic heart valve, and teacher on caval filtration and nanopathologies in the Interuniversity Masters in Nanotechology of Venice (Ca ’Foscari University, University of Padua, University of Verona), the University of Turin and the European Community; expertise in caval filtration and the prevention of pulmonary thromboembolism; and in pathologies induced by solid, inorganic nanoparticles

   Christof Plothe, DO, BSc, OST, HONS, MRO, DPO, HP Practice in Osteopathy, Bleichstraße 21, Alzey, Germany; practices in Ireland, the United States, Spain, and now Germany; author and co-author of books and articles about child birth hormones (oxytocin), toxicants, psychoactive pharmaceuticals, and disorders including autism

   Asgeir Saebo, MS in biology and chemistry University of Bergen, entrepreneur, widely published scientific author/inventor with 35 patents, and former President of American Oil Chemists Society

   Stephanie Seneff, PhD, Senior Research Scientist at the MIT Computer Science and Artificial Intelligence Laboratory (CSAIL), BS biophysics 1968, MS electrical engineering 1980, and PhD computer science in 1985, in addition to her interest in processing of natural sign systems, her current research has focusing on biosignaling systems and ways they are disrupted by toxicants and genetic engineering